Atrial Fibrillation

In a small, single-center trial, the novel Marshall-Plan ablation strategy improved 10-month arrhythmia recurrence compared with pulmonary vein isolation alone for persistent atrial fibrillation, a speaker reported.

Assessing safety and effectiveness of the PulseSelect PFA System (Medtronic) for treatment of atrial fibrillation.

Statin therapy may improve risk for stroke or transient ischemic attack among patients with atrial fibrillation compared with nonuse, regardless of concomitant anticoagulant use, a speaker reported.

Adults with atrial fibrillation and vascular dementia have a higher risk for stroke, rehospitalization and mortality compared with those with AF and Alzheimer’s disease, who have a higher risk for intercranial hemorrhage, data show.

New data suggest that 1.5 million cases of atrial fibrillation may be undiagnosed in the United States.

Healthy adults with spherical hearts, identified through a deep learning analysis of cardiac MRI images, were 31% more likely to develop atrial fibrillation and 24% more likely to develop cardiomyopathy, researchers reported.

Among older patients with atrial fibrillation and dementia, apixaban was associated with lower risk for stroke and major bleeding vs. dabigatran, rivaroxaban or warfarin, researchers reported.

An early rhythm control strategy for treatment of atrial fibrillation was cost-effective in a German population, according to new data from the EAST-AFNET 4 trial.

An Apple Watch feature designed to detect atrial fibrillation was associated with a low rate of false-positive detections but only modest sensitivity for detections in people with a history of AF, researchers reported.

The Society for Cardiovascular Angiography and Interventions and the Heart Rhythm Society released an updated expert consensus statement on transcatheter left atrial appendage closure for atrial fibrillation.